In this Section |
263932 Relationship between hypertension and health in the elderly population of JapanSunday, October 28, 2012
In general, the Japanese population is relatively healthy, with low rates of heart disease, obesity, diabetes, functioning difficulties, and the longest life expectancy in the world. At the same time, Japan has high rates of hypertension. Japan provides a unique opportunity to examine how various aspects of health influence each other and mortality in a relatively healthy population. The findings in the literature suggest that disease states might differentially influence health in different countries; compared to Japan, the United States has low life expectancy and higher rates of heart disease, obesity, diabetes, and functioning difficulties, however, the US has lower rates of hypertension compared to Japan. Using the Nihon University Japanese Longitudinal Study of Aging (NUJLSOA) (n=2195) this study examined the influence of hypertension on different aspects of health, namely mortality and cognitive performance, in the elderly population of Japan. Contrary to the literature on the US, in Japan hypertension was neither associated with mortality (OR: 0.91, 95% CI: 0.55-1.51) nor with cognitive performance using logistic and OLS-regression, respectively. Additionally, in a model that included hypertension, education, gender, and common hypertension comorbidities (diabetes, heart disease, and obesity) there was no association between the comorbidities and mortality. However, the female gender was associated with reduced mortality (OR: 0.50, 95% CI: 0.33-0.75). The findings suggest that aging may be conceptualized differently in different countries; in the US and other Western countries it appears that aging might be a constellation of diseases, whereas in Japan this is not the case.
Learning Areas:
Diversity and cultureEpidemiology Learning Objectives: Keywords: Hypertension, International
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have been conducting and presenting research on this dataset and cardiovascular health for the past four years. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 2075.0: Cardiovascular Disease Epidemiology Poster Session
|